An emerging biotech with transformative potential

About us

Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity.

Anocca’s technologies enable the highly precise and efficient analysis of T-cell biology required to deliver a range of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas. With a focus on delivering TCR-modified T-cell therapies (TCR-T) in oncology, Anocca is rapidly progressing a pipeline of novel T-cell therapies towards clinical trials utilizing our own manufacturing capabilities.

Anocca’s powerful technologies are also being deployed to develop a range of novel therapeutic and prophylactic products in oncology, infectious disease and autoimmunity.

Company leadership

Anocca’s leadership represents diverse backgrounds and experience. Together, the Management team and Board of Directors, with collective experience from the pharmaceutical, engineering and finance sectors, along with deep scientific knowledge and business acumen, are taking the company to the next stage in its development.

Hans Stråberg

Hans Stråberg

Rolf Kiessling

Rolf Kiessling

Reagan Jarvis

Reagan Jarvis

Mikael Blomqvist

Mikael Blomqvist

Mike Nishimura

Mike Nishimura

Hugh Salter

Hugh Salter

Fredrik Hansson

Fredrik Hansson

Klas Kärre

Klas Kärre

Ragnar Lindqvist

Ragnar Lindqvist

Adnane Achour

Adnane Achour

Luke Pase

Luke Pase

Jan Lundberg

Jan Lundberg

Ryan Hill

Ryan Hill

Reagan Jarvis

Reagan Jarvis

Viktor Arnkil

Viktor Arnkil

Hassan Aly

Hassan Aly

Mark Farmery

Mark Farmery

Careers

Anocca is a vibrant and energetic company offering a stimulating environment with opportunities for growth and career development. We are constantly seeking new talent to join our team. Job postings are listed here and if not, and you are interested in working with us, send your CV to jobs@anocca.com.

Scientist, Molecular Biology

The R&D group at Anocca is looking for a highly motivated scientist to join the DNA core team. The successful candidate will be involved in the development and implementation of cutting-edge molecular biology technologies, utilising state of the art equipment and liquid handling robotics. The position will involve hands-on lab work, with help from junior team member(s) under direct supervision, as well as interfacing with upstream and downstream teams to support their experimental needs.

The ideal candidate will have a comprehensive understanding of nucleic acid-based molecular biology fundamentals and development of optimised molecular assays. The candidate must have excellent English communication skills, the ability to analyse data and is meticulous in the documentation of experimental procedures and results. You must be capable of working as part of a team but also have the initiative to plan, coordinate and drive projects forward.

What we are looking for

  • PhD in molecular biology or related field
  • Strong theoretical and practical understanding of nucleic acid-based techniques
  • Experience with advanced vector design and cloning methodologies
  • Goal oriented with a focus on proficiency and attention to detail
  • Ability to work efficiently both independently and in a team environment
  • Fluent written and spoken English

Experience in the following techniques would be of merit

  • Synthetic biology workflows
  • Next Generation Sequencing and library preparation
  • Single cell sequencing methodologies
  • DNA and/or RNA molecular diagnostic testing

We offer: An international workplace, with a broad and engaged scientific workforce providing the opportunity to work at the exciting intersection of biotechnology and medicine.

Application: Applicants should send a CV and detailed cover letter in English to jobs@anocca.com.

Please note that we contact candidates that we would like to invite for an interview within 3 weeks after the advertisement has closed. Unsuccessful candidates will not be contacted.